Lv11
60 积分 2025-05-27 加入
PET image reconstruction with deep progressive learning
1小时前
已完结
Assessment of the diagnostic efficacy and clinical significance of [18F]AlF-NOTA-LM3 PET/CT in patients with well-differentiated neuroendocrine tumors
29天前
已完结
[177Lu]Lu-PSMA-617 versus cabazitaxel in patients with metastatic castration-resistant prostate cancer (TheraP): a randomised, open-label, phase 2 trial
2个月前
已完结
Radiotheranostics in oncology: current challenges and emerging opportunities
2个月前
已完结
Radiotheranostic landscape: A review of clinical and preclinical development
2个月前
已完结
Total Body PET/CT: Clinical Value and Future Aspects of Quantification in Static and Dynamic Imaging
2个月前
已完结
First-in-human study of PSMA-targeting agent, [18F]AlF-P16-093: dosimetry and initial evaluation in prostate cancer patients
2个月前
已完结
Total-body [68 Ga]Ga-PSMA-11 PET/CT improves detection rate compared with conventional [68 Ga]Ga-PSMA-11 PET/CT in patients with biochemical recurrent prostate cancer
2个月前
已完结
Combination of [18F]FDG and [18F]PSMA-1007 PET/CT predicts tumour aggressiveness at staging and biochemical failure postoperatively in patients with prostate cancer
2个月前
已完结
Total-body PET/CT with half-dose [68 Ga]Ga-PSMA-11 for biochemical recurrent prostate cancer: comparable diagnostic value to short axial field-of-view PET/CT with full-dose [68 Ga]Ga-PSMA-11
2个月前
已完结
皖公网安备34019202002308
